Biodesix (BDSX) Competitors $1.15 +0.01 (+0.88%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BDSX vs. GRAL, FLGT, AUNA, INNV, TALK, DCGO, CELC, EHAB, PSNL, and VMDShould you be buying Biodesix stock or one of its competitors? The main competitors of Biodesix include Grail (GRAL), Fulgent Genetics (FLGT), Auna (AUNA), InnovAge (INNV), Talkspace (TALK), DocGo (DCGO), Celcuity (CELC), Enhabit (EHAB), Personalis (PSNL), and Viemed Healthcare (VMD). These companies are all part of the "healthcare" industry. Biodesix vs. Grail Fulgent Genetics Auna InnovAge Talkspace DocGo Celcuity Enhabit Personalis Viemed Healthcare Biodesix (NASDAQ:BDSX) and Grail (NASDAQ:GRAL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk. Do analysts recommend BDSX or GRAL? Biodesix presently has a consensus price target of $3.06, suggesting a potential upside of 166.09%. Grail has a consensus price target of $16.00, suggesting a potential downside of 8.15%. Given Biodesix's stronger consensus rating and higher possible upside, equities research analysts plainly believe Biodesix is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodesix 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Grail 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor BDSX or GRAL? Biodesix received 29 more outperform votes than Grail when rated by MarketBeat users. Likewise, 74.36% of users gave Biodesix an outperform vote while only 0.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformBiodesixOutperform Votes2974.36% Underperform Votes1025.64% GrailOutperform VotesNo VotesUnderperform Votes3100.00% Which has better earnings & valuation, BDSX or GRAL? Grail has lower revenue, but higher earnings than Biodesix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodesix$49.09M3.41-$52.15M-$0.39-2.95GrailN/AN/AN/AN/AN/A Does the media refer more to BDSX or GRAL? In the previous week, Grail had 10 more articles in the media than Biodesix. MarketBeat recorded 11 mentions for Grail and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.00 beat Grail's score of 0.30 indicating that Biodesix is being referred to more favorably in the media. Company Overall Sentiment Biodesix Positive Grail Neutral Do insiders & institutionals believe in BDSX or GRAL? 21.0% of Biodesix shares are owned by institutional investors. 69.2% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is BDSX or GRAL more profitable? Grail has a net margin of 0.00% compared to Biodesix's net margin of -66.84%. Grail's return on equity of 0.00% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Biodesix-66.84% -275.79% -43.05% Grail N/A N/A N/A SummaryBiodesix beats Grail on 9 of the 13 factors compared between the two stocks. Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDSX vs. The Competition Export to ExcelMetricBiodesixMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$184.74M$3.09B$5.23B$8.96BDividend YieldN/A16.03%5.13%4.04%P/E Ratio-2.9515.3487.2917.29Price / Sales3.41200.801,255.8979.02Price / CashN/A426.0143.8235.97Price / Book23.004.925.324.79Net Income-$52.15M-$33.85M$122.78M$225.07M7 Day Performance-9.45%1.54%-0.19%1.51%1 Month Performance-14.18%0.28%3.72%4.68%1 Year Performance-41.03%13.27%27.31%20.92% Biodesix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDSXBiodesix3.8145 of 5 stars$1.15+0.9%$3.06+166.1%-41.0%$184.74M$49.09M-2.95220Short Interest ↓Positive NewsGRALGrail0.287 of 5 stars$18.53+4.5%$16.00-13.7%N/A$622.63M$117.67M0.001,360Short Interest ↑News CoverageFLGTFulgent Genetics4.1689 of 5 stars$17.99-1.7%$22.00+22.3%-34.5%$550.26M$277.76M-3.261,010Positive NewsAUNAAuna3.815 of 5 stars$7.30+2.7%$13.40+83.6%N/A$539.60M$4.34B0.0014,958Short Interest ↓Gap UpHigh Trading VolumeINNVInnovAge1.8521 of 5 stars$3.63+0.3%$6.00+65.3%-37.7%$491.70M$786.51M-30.252,000Short Interest ↓TALKTalkspace4.2308 of 5 stars$2.90-0.7%$4.38+50.9%+25.3%$489.88M$181.29M-290.00500Short Interest ↑News CoverageDCGODocGo2.2175 of 5 stars$4.02-1.5%$6.10+51.7%+28.3%$410.25M$694.97M14.364,164Analyst ForecastNews CoverageCELCCelcuity2.5069 of 5 stars$10.81-9.3%$29.17+169.8%-25.5%$401.38MN/A-4.1440News CoveragePositive NewsGap UpEHABEnhabit2.2065 of 5 stars$7.79+2.5%$8.75+12.3%-21.4%$391.71M$1.04B-3.3610,800Short Interest ↓PSNLPersonalis4.3268 of 5 stars$5.33-4.7%$8.56+60.6%+179.4%$376.55M$87.49M-3.17400Gap DownVMDViemed Healthcare2.2991 of 5 stars$7.90-0.6%N/A+10.3%$307.60M$214.30M29.26630Positive News Related Companies and Tools Related Companies GRAL Competitors FLGT Competitors AUNA Competitors INNV Competitors TALK Competitors DCGO Competitors CELC Competitors EHAB Competitors PSNL Competitors VMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BDSX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDSX Stock Alerts